The human transforming growth factor-alpha (TGF-a) gene is thought to contain ®ve introns and six exons, encoding a transmembrane precursor (proTGF-a) from which the mature polypeptide is released by proteolytic cleavage. We identi®ed a novel 32-nucleotide exon (exon a) within intron 5 and an alternative splice acceptor site in exon 6, splitting exon 6 into two segments: 6A and 6B. Therefore, in addition to wild type (wt) proTGF-a mRNA, which skips exon a, two novel proTGF-a variants are produced: Variant I (VaI), skipping exons a and 6A, and Variant II (VaII) which includes exon a and skips exon 6A. The only signi®cant di erence between variant and wt proTGF-a proteins is that the two wt carboxyl-terminal valines are replaced in the variants by ®ve or four other amino acids, respectively. Both variant TGF-a mRNAs were readily detected in human keratinocytes and tumor-derived cell lines. Their protein products were cleaved as e ciently as wt TGF-a in response to the calcium ionophore A23187. However, both variants (but not wt) reduced serum requirements for proliferation in CHO cells. In addition, VaIIexpressing CHO cells (not VaI or wt) formed foci in monolayer cultures. These results suggest that variant TGF-a precursors induce autonomous growth.